Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Freeman

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
JAMA Cardiology|November 13, 2017
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry StudyTaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
American Heart Journal|November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillationZak Loring, Peter Shrader, Larry A Allen, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Journal of the American Heart Association|October 30, 2018
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AFJeffrey B Washam, DaJuanicia N Holmes, Laine E Thomas, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|January 9, 2020
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillationTaku Inohara, DaJuanicia N Holmes, Karen Pieper, et al.
Circulation. Cardiovascular Interventions|May 16, 2020
Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II RegistryMatthew W Sherwood, Jonathan P Piccini, DaJuanicia N Holmes, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 12, 2020
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisionsFatima Ali-Ahmed, Karen Pieper, Rebecca North, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
JAMA Cardiology|November 13, 2017
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry StudyTaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
American Heart Journal|November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillationZak Loring, Peter Shrader, Larry A Allen, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Journal of the American Heart Association|October 30, 2018
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AFJeffrey B Washam, DaJuanicia N Holmes, Laine E Thomas, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Heart (British Cardiac Society)|January 9, 2020
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillationTaku Inohara, DaJuanicia N Holmes, Karen Pieper, et al.
Circulation. Cardiovascular Interventions|May 16, 2020
Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II RegistryMatthew W Sherwood, Jonathan P Piccini, DaJuanicia N Holmes, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 12, 2020
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisionsFatima Ali-Ahmed, Karen Pieper, Rebecca North, et al.
Pageof 27